» Articles » PMID: 37445352

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Jul 14
PMID 37445352
Authors
Affiliations
Soon will be listed here.
Abstract

This study aims to summarize the modifiable risk factors for pancreatic ductal adenocarcinoma (PDAC) that have been known for a long time, as well as information from the most recent reports. As a cancer with a late diagnosis and poor prognosis, accurate analysis of PDAC risk factors is warranted. The incidence of this cancer continues to rise, and the five-year survival rate is the lowest with respect to other tumors. The influence of cigarette smoking, alcohol consumption, and chronic pancreatitis in increasing the risk of pancreatic ductal adenocarcinoma is continually being confirmed. There are also newly emerging reports relating to the impact of lifestyle, including physical activity, the gut and oral microbiome, and hepatotropic viruses. A precise understanding of PDAC risk factors can help to identify groups of high-risk patients, and this may contribute to population awareness and education as well as earlier diagnoses with possible better treatment outcomes.

Citing Articles

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.

Dieli R, Lioy R, Crispo F, Cascelli N, Martinelli M, Lerose R Biomolecules. 2025; 15(2).

PMID: 40001578 PMC: 11853026. DOI: 10.3390/biom15020275.


A safe haven for cancer cells: tumor plus stroma control by DYRK1B.

Ems M, Brichkina A, Lauth M Oncogene. 2025; 44(6):341-347.

PMID: 39863750 PMC: 11790486. DOI: 10.1038/s41388-025-03275-6.


Radiomics and 256-slice-dual-energy CT in the automated diagnosis of mild acute pancreatitis: the innovation of formal methods and high-resolution CT.

Rocca A, Brunese M, Santone A, Varriano G, Vigano L, Caiazzo C Radiol Med. 2024; 129(10):1444-1453.

PMID: 39214954 PMC: 11480164. DOI: 10.1007/s11547-024-01878-9.


Theranostic nanoparticles for detection and treatment of pancreatic cancer.

Agarwal H, Bynum R, Saleh N, Harris D, MacCuaig W, Kim V Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(4):e1983.

PMID: 39140128 PMC: 11328968. DOI: 10.1002/wnan.1983.


Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma.

Singh G, Kutcher D, Lally R, Rai V Cancers (Basel). 2024; 16(11).

PMID: 38893220 PMC: 11171042. DOI: 10.3390/cancers16112101.


References
1.
Momi N, Ponnusamy M, Kaur S, Rachagani S, Kunigal S, Chellappan S . Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation. Oncogene. 2012; 32(11):1384-95. PMC: 3427417. DOI: 10.1038/onc.2012.163. View

2.
Askari M, Tsao M, Schuller H . The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol. 2005; 131(10):639-48. DOI: 10.1007/s00432-005-0002-7. View

3.
Liu T, Song C, Zhang Y, Siyin S, Zhang Q, Song M . Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study. Int J Cancer. 2021; 150(6):1018-1028. PMC: 9300134. DOI: 10.1002/ijc.33891. View

4.
Pushalkar S, Hundeyin M, Daley D, Zambirinis C, Kurz E, Mishra A . The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018; 8(4):403-416. PMC: 6225783. DOI: 10.1158/2159-8290.CD-17-1134. View

5.
Wang H, Chen X, Chen X, Zhang W, Liu K, Wang Y . Associations between hepatitis B virus exposure and the risk of extrahepatic digestive system cancers: A hospital-based, case-control study (SIGES). Cancer Med. 2021; 10(11):3741-3755. PMC: 8178500. DOI: 10.1002/cam4.3901. View